@Blakej01 The double or triple break into 7's feels good for longs.Piper upgrade was silly but at least an upgrade. Still speculative play

? Danny Beee (@CashSteroids) May. 14 at 01:31 PM

But few investors saw that happening after hearing Wednesday's conference.

@Blakej01 Partnership announcement = boom, FDA approval = boom. And there will be plenty of other catalysts down the road, IMO.

? Alex Vazquez (@alexvazquez2121) May. 14 at 02:33 PM
 

At the time of publication the author held no positions in any of the stocks mentioned.

This article represents the opinion of a contributor and not necessarily that of TheStreet or its editorial staff.

>>Read More: Why Marissa Mayer Just Bought the Next Snapchat

>>Read More: Why the OpenStack Cloud Bubble Will Soon Burst

>>Read More: Gold ETFs Continue to Inflict Maximum Frustration

If you liked this article you might like

Pharma Bro Martin Shkreli Awaits Jury Decision in Fraud Case

Mannkind in Free Fall After Changes to Insulin Product, Sales Force

Mannkind Stock Drops Following Changes to Its Insulin Product

Laser-Maker Cynosure Leads Biotech Movers Ahead of Market Open

Insulin Drug Offers Hope for MannKind